COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience

BACKGROUND: As of November 2020, severe acute respiratory syndrome coronavirus 2 has resulted in 55 million infections worldwide and more than 1.3 million deaths from coronavirus disease 2019 (COVID-19). Outcomes following severe acute respiratory syndrome coronavirus 2 infection in individuals with...

Descripción completa

Detalles Bibliográficos
Autores principales: Shields, Adrian M., Burns, Siobhan O., Savic, Sinisa, Richter, Alex G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Academy of Allergy, Asthma & Immunology 2021
Materias:
Covid-19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737531/
https://www.ncbi.nlm.nih.gov/pubmed/33338534
http://dx.doi.org/10.1016/j.jaci.2020.12.620

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737531/
https://www.ncbi.nlm.nih.gov/pubmed/33338534
http://dx.doi.org/10.1016/j.jaci.2020.12.620

Ejemplares similares